Clinical spectrum of ischaemic arterial diseases associated with COVID-19: a series of four illustrative cases.
Henri GuilletRomain GalletVincent PhamThomas D'HumièresRaphaelle HuguetPascal LimMarc MichelMehdi KhellafPublished in: European heart journal. Case reports (2020)
Cardiovascular risk factors such as hypertension, obesity, and diabetes are comorbidities most frequently found in patients with a severe COVID-19 infection and are associated with a higher death rate. Our goal is to provide an overview of the clinical spectrum of ischaemic arterial events that may either reveal or complicate COVID-19. Several suspected pathophysiological mechanisms could explain the association between cardiovascular events and COVID-19 (role of systemic inflammatory response syndrome, endothelial dysfunction, activation of coagulation cascade leading to a hypercoagulability state, virus-induced secondary antiphospholipid syndrome). We need additional studies of larger size, to estimate the incidence of these arterial events and to assess the efficacy of anticoagulation therapy.
Keyphrases
- coronavirus disease
- cardiovascular events
- sars cov
- cardiovascular risk factors
- cardiovascular disease
- inflammatory response
- type diabetes
- metabolic syndrome
- coronary artery disease
- blood pressure
- respiratory syndrome coronavirus
- insulin resistance
- drug induced
- atrial fibrillation
- risk factors
- weight loss
- venous thromboembolism
- pulmonary embolism
- immune response
- early onset
- gene expression
- high glucose
- lps induced
- lipopolysaccharide induced
- glycemic control
- toll like receptor
- dna methylation
- case report
- skeletal muscle
- physical activity
- mesenchymal stem cells
- cell therapy